Studies on the haemotoxicity of chloramphenicol succinate in the Dunkin Hartley guinea pig

International Journal of Experimental Pathology

Volumn 83, Issue 5, 2002, Pages 225-238

  Turton, J A ^a   Andrews, C M ^b   Havard, A C ^a,c   Williams, T C ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Blood; Bone marrow; Chloramphenicol guinea pig; Haemotoxicity

Indexed keywords

CHLORAMPHENICOL HEMISUCCINATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD TOXICITY; BONE MARROW APLASIA; BONE MARROW DEPRESSION; CELL COUNT; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE; FEEDING; FEMALE; GUINEA PIG; HEMOCONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE; RODENT;

ANEMIA; ANIMALS; ANTI-BACTERIAL AGENTS; BONE MARROW CELLS; CHLORAMPHENICOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE COUNT; FEMALE; GUINEA PIGS; MODELS, ANIMAL; RETICULOCYTE COUNT; TIME FACTORS;

EID: 0036819914     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2003.00232.x     Document Type: Article

References (72)

1. ALTER B.P., POTTER N.U. & LI F.P. (1978) Classification and aetiology of the aplastic anaemias. Clin. Haematol. 7, 431-465.
2. ALTER B.P. & YOUNG N.S. (1998) The bone marrow failure syndromes. In: Haematology of Infancy and Childhood. (Eds D.G. NATHAN & S.H. ORKIN), Philadelphia: W.B. Saunders, pp. 111-222.
3. ANDREWS C.M. (2000) Studies on the haemotoxicty of busulphan and chloramphenicol in the B6C3F1 mouse. PhD Thesis. London: University of London.
4. ANDREWS C.M., WILLIAMS T.C. & TURTON J.A. (1998) Long-term haematological alterations in female B6C3F1 mice treated with bulsulphan. Comp. Haematol. Int. 8, 125-138.
5. BEST W.R. (1967) Chloramphenicol-associated blood dyscrasias. J. Am. Med. Assoc. 201, 99-106.
6. BOYNE R. & ARTHUR J.R. (1990) Anaemia and changes in erythrocyte morphology associated with copper and selenium deficiencies and dietary restriction in rats. Res. Vet. Sci. 49, 151-156.
7. CHAPLIN S. (1986) Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol - Part II. Adverse Drug React. Acute Poison. Rev. 3, 181-196.
8. COHEN T. & CREGER W.P. (1967) Acute myeloid leukemia following seven years of aplastic anemia induced by chloramphenicol. Am. J. Med. 43, 762-770.
9. DOLLERY C. (1999) Therapeutic Drugs. Edinburgh: Churchill Livingstone, pp. C168-C172.
10. DUNKIN G.W., HARTLEY P., LEWIS-FANING E. & RUSSELL W.T. (1930) A comparative biometric study of albino and coloured guinea-pigs from the point of view of their suitability for experimental use. J. Hyg. (Camb.). 30, 311-333.
11. FAO/WHO (1988) Expert Committee on Food Additives. Chloramphenicol. In: Toxicological Evaluation of Certain Veterinary Drug Residues in Food (WHO Food Additives Series 23). Geneva: World Health Organisation, pp. 1-71.
12. FESTING M.F.W., DIAMANTI P. & TURTON J.A. (2001) Strain differences in haematological response to chloramphenicol succinate in mice: implications for toxicological research. Food Chem. Toxicol. 39, 375-383.
13. FRAUNFELDER F.T., MORGAN R.L. & YUNIS A.A. (1993) Blood dyscrasias and topical ophthalmic chloramphenicol. Am. J. Ophthalmol. 115, 812-813.
14. FREEDMAN M.H. (2000) Inherited forms of bone marrow failure. In: Haematology: Basic Principles and Practice (Eds R. HOFFMAN ET AL.). New York: Churchill Livingstone, pp. 260-297.
15. GRUHZIT O.M., FISKEN R.A., REUTNER T.F. & MARTINO E. (1949) Chloramphenicol (chloromycetin), an antibiotic. Pharmacological and pathological studies in animals. J. Clin. Invest. 28, 943-952.
16. HAAK H.L. (1980) Experimental drug-induced aplastic anaemia. Clinics Haematol. 9, 621-639.
17. HAVARD A., ANDREWS C.M., WILLIAMS T.C. & TURTON J.A. (1999) Chloramphenicol induces reversible dose-related reticulocytopenia, not aplastic anaemia, in the guinea pig. Hum. Exp. Toxicol. 18, 764.
18. 1 mouse. Hum. Exp. Toxicol. 17, 8-17.
19. HOLT D., HARVEY D. & HURLEY R. (1993) Chloramphenicol toxicity. Adv. Drug React. Toxicol. Rev. 12, 83-95.
20. HOLT D., HURLEY R. & HARVEY D. (1995) A reappraisal of chloramphenicol metabolism; detection and quantification of metabolites in the sera of children. J. Antimicrob. Chemother. 35, 115-127.
21. HOME OFFICE (1989) Code of Practice for the Housing and Care of Animals Used in Scientific Procedures. London: Her Majesty's Stationary Office.
22. IARC (1990) Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Chloramphenicol, Vol. 50, pp. 169-193. Lyon: IARC.
23. KNOSPE W.H. (1988) Long-term bone marrow damage after irradiation. In: Hematopoiesis: Long-term Effects of Chemotherapy and Radiation (Eds N.G. TESTA & R.P. GALE). New York: Marcel Dekker, pp. 93-130.
24. KRAKOFF I.H., KARNOFSKY D.A. & BURCHENAL J.H. (1955) Effects of large doses of chloramphenicol on human subjects. New Engl. J. Med. 253, 7-10.
25. KRISHNA G., AYKAC I. & SIEGEL D. (1981) Recent studies on the mechanisms of chloramphenicol activation responsible for aplastic anaemia. In: Safety Problems Related to Chloramphenicol, and Thiamphenicol. (Eds Y. NAJEAN, G. TOGNONI & A.A. YUNIS). New York: Raven Press, pp. 5-16.
26. KUMANA C.R., LI K.Y. & KOU M. (1993) Do chloramphenicol blood dyscrasias occur in Hong Kong? Adverse Drug React. Toxicol. Rev. 12, 97-106.
27. KUMAR P. & VERMA I.C. (1993) Antibiotic therapy for bacterial meningitis in children in developing countries. Bull. World Health Org. 71, 183-188.
28. KURTZMAN G. & YOUNG N. (1989) Viruses and bone marrow failure. Ballière's Clin. Haematol. 2, 51-67.
29. KUSHWAHA K.P., VERMA R.B., SINGH Y.D. & RATHI A.K. (1994) Surveillance of drug induced diseases in children. Indian J. Pediatr. 61, 357-365.
30. LANDEMORE G., QUILLEC M., LETAIEF S.E. & IZARD J. (1994) The proteoglycan skeleton of the Kurloff body as evidenced by cuprolinic blue staining. Histochem. J. 26, 571-581.
31. LEVIN S., SEMLER D. & RUBEN Z. (1993) Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol. Pathol. 21, 1-14.
32. LOEB W.F., BANNERMAN R.M., RININGER B.F. & JOHNSTON A.J. (1978) Haematologic disorders (Chapter II). In: Pathology of Laboratory Animals (Eds K. BENIRSCHKE, F.M. GARNER & T.C. JONES). New York: Springer Verlag, pp. 889-1050.
33. MAEJIMA K. & NAGASE S. (1991) Effect of starvation and refeeding on the circadian rhythms of haematological and clinico-biochemical values, and water intake of rats. Exp. Anim. Tokyo 40, 389-393.
34. MANYAN D.R., ARIMURA G.K. & YUNIS A.A. (1972) Chloramphenicol-induced erythroid suppression and bone marrow ferrochelatase activity in dogs. J. Laboratory Clin. Med. 79, 137-144.
35. MANYAN D.R. & YUNIS A.A. (1970) The effect of chloramphenicol treatment on ferrochelatase activity in dogs. Biochem. Biophys. Res. Commun. 41, 926-931.
36. MASON J.H. (1940) The date of the first use of guinea-pigs and mice in biological research. J. Afr. Vet. Med. Assoc. 11, 22-25.
37. MILLER A.M., ARIMURA G.K., GROSS M.A. & YUNIS A.A. (1978) In vitro evidence for genetically determined variations in marrow erythroid sensitivity. Exp. Hematol. 6, 455-460.
38. MOORE D.M. (2000) Haematology of the guinea pig. In: Schalm's Veterinary Haematology (Eds B.F. FELDMAN, J.G. ZINKL & N.C. JAIN). Philadelphia: Lippincott Williams & Wilkins, pp. 1107-1119.
39. MORLEY A. & BLAKE J. (1974) An animal model of chronic hypoplastic marrow failure. Late marrow failure after busulphan. Blood 44, 49-56.
40. MORLEY A., TRAINOR K. & REMES J. (1976) Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol. Br. J. Haematol. 32, 525-531.
41. MURRAY T., DOWNEY K.M. & YUNIS A.A. (1982) Degradation of isolated deoxyribonucleic acid mediated by nitrosochloramphenicol. Biochem. Pharmacol. 31, 2291-2296.
42. NAGAO T. & MAUER A.M. (1969) Concordance for drug induced aplastic anaemia in identical twins. New Engl. J. Med. 281, 7-11.
43. PARFITT K. (1999) Martindale: The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press, pp. 182-184.
44. PAZDERNIK T.L. & CORBETT M.D. (1980) Role of chloramphenicol reduction products in aplastic anaemia. Pharmacology 20, 878-894.
45. ++ dependency. Inflammation 20, 647-671.
46. RICH M.L., RITTERHOFF R.J. & HOFFMANN R.J. (1950) A fatal case of aplastic anaemia following chloramphenicol (chloromycetin) therapy. Ann. Intern. Med. 33, 1459-1467.
47. ROBIN E., BERMAN M., BHOOPALAM N., COHEN H. & FRIED W. (1981) Induction of lymphomas in mice by busulphan and chloramphenicol. Cancer Res. 41, 3478-3482.
48. ROSENBACH L.M., CAVILES A.P. & MITUS W.J. (1960) Chloramphenicol toxicity: reversible vacuolization of erythroid cells. New Engl. J. Med. 263, 274-278.
49. ROSENBERG A. & MARCUS O. (1974) Effect of chloramphenicol on reticulocyte aminolaevulinic acid synthetase in rabbits. Br. J. Haematol. 26, 79-83.
50. RUBIN D., WEISBERGER A.S., BOTTI R.E. & STORAOSLI J.P. (1958) Changes in iron metabolism in early chloramphenicol toxicity. J. Clin. Invest. 37, 1286-1292.
51. SAIDI P., WALLERSTEIN R.O. & AGGELER P.M. (1961) Effect of chloramphenicol or erythropoiesis. J. Lab. Clin. Med. 57, 247-256.
52. SCHROBER R., KOSEK J.C. & WOLF P.L. (1972) Chloramphenicol-induced vacuoles. Their ultrastructure in bone marrow pronormoblasts and immature myeloid cells. Arch. Path. 94, 298-302.
53. SCOTT J.L., FINEGOLD S.M., BELKIN G.A. & LAWRENCE J.S. (1965) A controlled double blind study of the haematologic toxicity of chloramphenicol. New Engl. J. Med. 272, 1137-1142.
54. SUTHERLAND S.D. & FESTING M.F.W. (1987) The guinea-pig. In: The UFAW Handbook on the Care and Management of Laboratory Animals (Ed. T.B. POOLE). 6th edn. Harlow: Longman, pp. 393-410.
55. TAOUJI S., DEBOUT C. & IZARD J. (1996) Arylsulfatase B in Kurloff cells: increased activity of anionic isoforms in guinea pig acute lymphoblastic leukemia. Leukemia Res. 20, 259-264.
56. TREVETT A.J., NARAQI S. & WEMBRI J. (1992) Typhoid fever complicated by chloramphenicol toxicity, ataxia and psychosis. Papua New Guinea Med. J. 35, 205-209.
57. TURTON J.A., ANDREWS C.M., HAVARD A.C. ET AL. (2002) Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover rat. Food Chem. Toxicol. 40, 1849-1861.
58. TURTON J.A., HAVARD A.C., ROBINSON S. ET AL. (2000) An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB/c mouse. Food Chem. Toxicol. 38, 925-938.
59. TURTON J.A., YALLOP D., ANDREWS M., FAGG R., YORK M. & WILLIAMS T.C. (1999) Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat. Hum. Exp. Toxicol. 18, 566-576.
60. VINCENT P.C. (1984) In vitro evidence of drug action in aplastic anaemia. Blut 49, 3-12.
61. VOLINI I.F., GREENSPAN L., EHRLICH L., GUNNER J.A., FELSENEELD O. & SCHWARTZ S.O. (1950) Hemopoietic changes during administration of chloramphenicol (chloromycetin). J. Am. Med. Assoc. 142, 1333-1355.
62. WALLERSTEIN R.O., CONDIT P.K., KASPER C.K., BROWN J.W. & MORRISON F.R. (1969) Statewide study of chloramphenicol therapy and fatal aplastic anaemia. J. Am. Med. Assoc. 208, 2045-2050.
63. WELCH H., LEWIS C.N. & KERLAN I. (1954) Blood dyscrasias. A nationwide survey. Antibiot. Chemother. 4, 607-623.
64. YOUNG N.S. & ALTER B.P. (1994) Aplastic Anemia: Acquired and Inherited. Philadelphia: W.B. Saunders.
65. YOUNG N.S. & MACIEJEWSKI J.P. (2000) Aplastic anaemia. In: Haematology: Basic Principles and Practice (Eds R. HOFFMAN, ET AL.). New York: Churchill Livingston, pp. 297-331.
66. YOUNG N.S. & MACIEJEWSKI (1997) The pathophysiology of acquired aplastic anaemia. New Engl. J. Med. 336, 1365-1372.
67. YUNIS A.A. (1973) Chloramphenicol-induced bone marrow suppression. Semin. Haematol. 10, 225-234.
68. YUNIS A.A. (1978) Mechanisms underlying marrow toxicity from chloramphenicol and thiamphenicol. In: The Year in Haematology (Eds R. SILVER, J. LE BUE & A.S. GORDON). New York: Plenum Press, pp. 143-170.
69. YUNIS A.A. (1988) Chloramphenicol: relation of structure to activity and toxicity. Ann. Rev. Pharmacol. Toxicol. 28, 83-100.
70. YUNIS A.A. & BLOOMBERG G.R. (1964) Chloramphenicol toxicity, clinical features and pathogenesis. Prog. Haematol. 4, 138-159.
71. YUNIS A.A., SMITH U.S. & RESTREPPO A. (1970) Reversible bone marrow suppression from chloramphenicol: A consequence of mitochondrial injury. Arch. Intern. Med. 126, 272-275.
72. ZAPOROWSKA H. & WASILEWSKI W. (1991) Significance of reduced food and water consumption with vanadium. Comp. Biochem. Physiol. 99C, 349-352.